Lista de obras - Jun Zhang - Dominio Público Uruguay

Addition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients

artículo científico publicado en 2017

Advanced stage melanoma therapies: Detailing the present and exploring the future

artículo científico publicado en 2018

Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?

artículo científico publicado en 2018

Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy

scientific article published on 05 September 2018

Cell Block as a Surrogate for Programmed Death-Ligand 1 Staining Testing in Patients of Non-Small Cell Lung Cancer

artículo científico publicado en 2020

Central Nervous System Pseudoprogression With Nivolumab in a Patient With Squamous Cell Lung Cancer Followed by Prolonged Response

scientific article published on 01 September 2018

Contribution of alternative splicing to breast cancer metastasis

artículo científico publicado en 2019

Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells.

artículo científico publicado en 2004

Cystatin m: a novel candidate tumor suppressor gene for breast cancer.

artículo científico publicado en 2004

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.

artículo científico publicado en 2016

Early detection of lung cancer by using an autoantibody panel in Chinese population

artículo científico publicado en 2017

Ethanol alters cellular activation and CD14 partitioning in lipid rafts.

artículo científico publicado en 2005

Getting familiar with the forthcoming eighth edition of TNM classification of lung cancer: from the T to N and M descriptors.

artículo científico publicado en 2016

HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib

scientific article published on 01 March 2019

Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma.

artículo científico publicado en 2018

High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules

artículo científico publicado en 2015

Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

artículo científico publicado en 2017

Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop

scientific article published on 04 June 2019

IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer

artículo científico publicado en 2020

Identification of recurrent fusion genes across multiple cancer types

scientific article published in Scientific Reports

Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer

artículo científico publicado en 2017

LKB1 Tumor Suppressor: Therapeutic Opportunities Knock when LKB1 Is Inactivated.

artículo científico publicado en 2014

Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis

artículo científico publicado en 2018

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

scientific article published on 12 February 2019

Metadherin enhances vulnerability of cancer cells to ferroptosis

scientific article published on 17 September 2019

Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC.

artículo científico publicado en 2017

Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction

artículo científico publicado en 2018

Novel expression of CST1 as candidate senescence marker.

artículo científico publicado en 2011

O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

artículo científico publicado en 2017

O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate

artículo científico publicado en 2017

Ophiopogon japonicus inhibits radiation-induced pulmonary inflammation in mice

scientific article published on 01 November 2019

Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status

artículo científico publicado en 2017

ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer.

artículo científico publicado en 2019

Response to Erlotinib in a Patient with Compound EGFR L747S and Exon 19 Deletion

artículo científico publicado en 2018

SBRT to adrenal metastases provides high local control with minimal toxicity.

artículo científico publicado en 2017

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

artículo científico publicado en 2019

Targeting DNA Replication Stress for Cancer Therapy

artículo científico publicado en 2016

Targeting HER (ERBB) signaling in head and neck cancer: An essential update.

artículo científico

Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities.

artículo científico publicado en 2015

Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges

artículo científico publicado en 2015

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces Together

artículo científico publicado en 2018

Lista de obras de Jun Zhang

Addition of bevacizumab for malignant pleural effusion as the manifestation of acquired EGFR-TKI resistance in NSCLC patients

Advanced stage melanoma therapies: Detailing the present and exploring the future

Atezolizumab after Nivolumab-Induced Inflammatory Polyarthritis: Can Anti-PD-L1 Immunotherapy Be Administered after Anti-PD-1-Related Immune Toxicities?

Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy

Cell Block as a Surrogate for Programmed Death-Ligand 1 Staining Testing in Patients of Non-Small Cell Lung Cancer

Central Nervous System Pseudoprogression With Nivolumab in a Patient With Squamous Cell Lung Cancer Followed by Prolonged Response

Contribution of alternative splicing to breast cancer metastasis

Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cells.

Cystatin m: a novel candidate tumor suppressor gene for breast cancer.

EGFR TKIs plus WBRT Demonstrated No Survival Benefit Other Than That of TKIs Alone in Patients with NSCLC and EGFR Mutation and Brain Metastases.

Early detection of lung cancer by using an autoantibody panel in Chinese population

Ethanol alters cellular activation and CD14 partitioning in lipid rafts.

Getting familiar with the forthcoming eighth edition of TNM classification of lung cancer: from the T to N and M descriptors.

HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib

Heterogeneity of PD-L1 Expression Among the Different Histological Components and Metastatic Lymph Nodes in Patients With Resected Lung Adenosquamous Carcinoma.

High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules

Honokiol Radiosensitizes Squamous Cell Carcinoma of the Head and Neck by Downregulation of Survivin.

Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop

IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer

Identification of recurrent fusion genes across multiple cancer types

Immunotherapy with Dendritic Cells Modified with Tumor-Associated Antigen Gene Demonstrates Enhanced Antitumor Effect Against Lung Cancer

LKB1 Tumor Suppressor: Therapeutic Opportunities Knock when LKB1 Is Inactivated.

Lobar versus sub-lobar surgery for pulmonary typical carcinoid, a population-based analysis

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

Metadherin enhances vulnerability of cancer cells to ferroptosis

Mutational Landscape of cfDNA Identifies Distinct Molecular Features Associated With Therapeutic Response to First-Line Platinum-Based Doublet Chemotherapy in Patients with Advanced NSCLC.

Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction

Novel expression of CST1 as candidate senescence marker.

O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate.

O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate

Ophiopogon japonicus inhibits radiation-induced pulmonary inflammation in mice

Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status

ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer.

Response to Erlotinib in a Patient with Compound EGFR L747S and Exon 19 Deletion

SBRT to adrenal metastases provides high local control with minimal toxicity.

Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy

Targeting DNA Replication Stress for Cancer Therapy

Targeting HER (ERBB) signaling in head and neck cancer: An essential update.

Targeting KRAS-mutant non-small cell lung cancer: challenges and opportunities.

Tuberculosis in umbilical cord blood transplant recipients: clinical characteristics and challenges

Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces Together